$GSHD

Company Insider Scoops Up 1,600 Shares of Insurance Stock

Goosehead Insurance, Inc. (GSHD) director Peter R. Lane bought 1,600 shares of Class A common stock on July 31, 2026, according to an SEC Form 4. The weighted average purchase price was $63.14, versus a $62.00 close that day. The stock had a -32% one-year total return ending on the transaction date.

Original reporting
Published Aug 6, 2026, 2:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 3:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Company Insider Scoops Up 1,600 Shares of Insurance Stock — source image
Decision brief

The 30-second read

$GSHDBullishLow
01

Why it matters

Traders may treat the buy as a small positive sentiment input, but without accompanying guidance, earnings, or material corporate action, it is unlikely to drive a sustained repricing.

02

Market read

A newly reported insider buy can slightly improve sentiment, but the disclosed transaction size and lack of new fundamentals limit trading impact.

03

What to watch

The article does not disclose whether the director’s purchase was part of an established trading plan, nor does it provide any new company-specific financial update.

Relevance 4/10Novelty 4/10Timing: today’s read-through of a newly reported Form 4 insider purchase

Background

The article summarizes an SEC Form 4 direct purchase by Goosehead Insurance director Peter R. Lane and frames it against recent stock performance and valuation metrics.

Company-level read

Ticker impact

$GSHDBullishMedium confidence
Context

Goosehead director Peter R. Lane bought 1,600 shares on July 31 at a $63.14 weighted average price, per Form 4.

Expected impact

Near-term impact likely limited; any effect is more sentiment than catalyst.

Evidence & confidence

Insider purchases can support bullish sentiment, but the disclosed size (1,600 shares) is small versus the company’s market cap and the article provides no new operational or financial guidance.

Market effects

Minimal spillover to insurance brokerage peers; this is company-specific insider activity without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The purchase may reflect routine compensation, diversification, or pre-planned trading rather than a strong valuation signal.

Key entities

  • Goosehead Insurance, Inc.

    Personal lines insurance brokerage with a direct corporate and franchise distribution model.

  • Peter R. Lane

    Director who reported a direct purchase of 1,600 shares on July 31, 2026.

Related articles

$GSHDHigh

GOOSEHEAD INSURANCE, INC. ANNOUNCES SECOND QUARTER 2026 RESULTS

Goosehead Insurance, Inc. (GSHD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a20260630-earningsrelease1.htm EX-99.1 Document GOOSEHEAD INSURANCE, INC. ANNOUNCES SECOND QUARTER 2026 RESULTS – Total Revenue Increased 21% and Core Revenue* Grew 10% over the Prior-Year Period – – Total Written Premium increased 14% to $1.34 billion over the Prior-Ye

$RAREHighAI 9/10

Ultragenyx agrees to sell voucher for US$210M

Ultragenyx Pharmaceutical (NASDAQ: RARE) agreed to sell a rare pediatric disease priority review voucher for $210M, nearly half its cash reserves. The deal, subject to regulatory approval, follows the FDA's August approval of its Genglycos gene therapy. Shares rose 2.97% on the news. Ultragenyx plans to use proceeds to advance rare disease therapies and support profitability. The price is within the range of recent voucher transactions, such as Rocket Pharmaceuticals' $180M deal.

$SLBMed

How New Energy Contracts Will Impact SLB (SLB) Stock

SLB (SLB) secured multi-year energy contracts with Aramco and ExxonMobil, expanding its backlog in onshore and deepwater infrastructure. Analysts project $43.0b revenue and $5.5b earnings by 2029, with potential upside. The company's focus on digital and data center solutions is seen as a driver for higher revenue.

$CEGMed

Big Tech Keeps Signing Nuclear Deals With the Same Company. Here's Who It Is and Why That Matters More Than Any Single Deal.

Constellation Energy (CEG) signed a deal with Alphabet's Google to supply 890 MW of nuclear power, highlighting its role in powering AI growth for tech giants. CEG operates outside regulated utilities, offering direct power sales to companies like Microsoft, Meta, and Amazon. Its scale, diverse energy portfolio, and long-term contracts support growth, though its stock remains 25% below 2025 highs.

$LCIDMed

Lucid Builds Fewer EVs Than It Sells As CEO’s Cash-Preservation Reset Takes Hold

Lucid Group reported Q3 production of 2,954 EVs and deliveries of 3,806, down from last year. The company is reducing inventory and aligning output with demand under CEO Silvio Napoli's operational reset. Lucid aims to improve cash flow by $1.4B in 2026. Analysts expect a Q3 loss of $2.30 per share and revenue of $570.42M. The stock has a Hold consensus rating with an average price target of $10.20.